Blackstone Group Inc.
- SEC CIK
- 0001393818
- Latest filing
- Aug 14, 2026
EFTR holding history
eFFECTOR Therapeutics, Inc. in every 13F filed by Blackstone Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EFTR overviewAll 13F holders of EFTRFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −52,343−100.0% | Sold out | Holders |
| Q3 2024 | 52,343 | $2.04K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 52,343 | $15.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 52,343 | $753.2K | <0.1% | 00.0% | UnchangedConverted for a 1-for-25 split | Holders |
| Q4 2023 | 1,308,587 | $611.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1,308,587 | $785.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1,308,587 | $1.09M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,308,587 | $461.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 1,308,587 | $559.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,308,587 | $749.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,308,587 | $1.86M | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,308,587 | $5.25M | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,308,587 | $7.80M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 1,308,587 | $18.4M | <0.1% | +1,308,587 | New | Holders |